SCHEMBL5740193

SCHEMBL5740193

Nc1cc2ccc(O)cc2s1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 10/20 0.55
▸ ESR2 Q92731 10/20 0.55
▸ CA2 P00918 3/20 0.55
▸ HTT P42858 2/20 0.50
▸ GAA P10253 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ HSD17B1 P14061 1/20 0.45
▸ APP P05067 1/20 0.42
▸ BACE1 P56817 1/20 0.40
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA4 P22748 1/20 0.40
▸ CA6 P23280 1/20 0.40
▸ CA5A P35218 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ CA14 Q9ULX7 1/20 0.40
▸ CA5B Q9Y2D0 1/20 0.40
▸ CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7898110 0.77 CA2 (0.55) CA2HTTGAAAPPBACE1
SCHEMBL28145858 0.77 ESR1 (0.59) ESR1ESR2CA2HTTGAA
SCHEMBL16471396 0.74 MAPT (0.50) ESR1ESR2CA2GAAAPP
SCHEMBL4283955 0.74 MAPT (0.45) CA2HTTAPPBACE1CYP1A2
SCHEMBL5241572 0.74 ESR2 (0.58) ESR1ESR2CA2HTTGAA
SCHEMBL17001366 0.74 GFER (0.50) CA2APPBACE1CYP1A2
SCHEMBL10369249 0.74 ESR1 (0.55) ESR1ESR2CA2HTTGAA
SCHEMBL11886144 0.74 CA2 (0.42) CA2APPBACE1CA12CA4
SCHEMBL5239964 0.74 ESR1 (0.53) ESR1ESR2CA2HTTGAA
SCHEMBL10370704 0.74 ESR1 (0.50) ESR1ESR2CA2HTTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7253204-B2 Antiproliferative agents METHYLGENE INC. (CA) 2007-08-07 — — US disclosed
US-7253204-B2 Antiproliferative agents METHYLGENE INC. (CA) 2007-08-07 — — US disclosed
EP-1670804-A2 HETEROBICYCLIC COMPOUNDS AS PHARMACEUTICALLY ACTIVE AGENTS GPC Biotech AG (DE) 2006-06-21 — — EP disclosed
WO-2005023818-A2 HETEROBICYCLIC COMPOUNDS AS PHARMACEUTICALLY ACTIVE AGENTS GPC BIOTECH AG (DE) 2005-03-17 — — WO disclosed
Send feedback